United States Biocatalysts Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034)

United States Biocatalysts Market Growth

The growth of the United States biocatalysts market is primarily driven by increased sales of pharmaceutical products. Biocatalysts, especially enzymes, are widely used to produce active pharmaceutical ingredients (APIs) by the synthesis of complex pharmaceutical compounds through a sustainable, eco-friendly biocatalytic process. This reduces the need for toxic reagents and harsh conditions, which often leave harmful by-products at the end.

Moreover, the popularity of biologics and personalised medicines is propelling the use of biocatalysts for precise and efficient manufacturing of medicinal drugs in the country. According to the National Health Institute, the country recorded one of the highest sales values for pharmaceutical products globally in 2022, landing on revenue exceeding USD 600 billion. Further growth in the pharmaceutical industry is inevitable during the coming years owing to rising health concerns in the US. This is expected to positively impact the country’s production of biocatalysts for medicinal applications.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Key Trends and Recent Developments

United States Biocatalysts Market Trends

The United States biocatalysts market development is driven by emerging health benefits from its use in the pharmaceutical, food and beverages sectors. As enzymes, biocatalysts enable the production of food, beverages, and medicinal products through a sustainable eco-friendly process. Also, they serve as an ideal alternative to chemical additives and flavour enhancers resulting in the development of healthier and more natural products. Besides these commonly known benefits, biocatalysts are also being used to add nutritional qualities to food products. For instance, in the latest development, Kraft Heinz, a US-based food and beverage company, funded research by a group of Harvard scientists that developed an enzyme that reduced the amount of sugar absorbed by the bloodstream, turning it into a fibre good for the gut health, when added to a chocolate bar, encased in an edible substance. The research contributed significantly to Kraft’s objective to cut down 60 million pounds of sugar from its products by 2025.

United States Biocatalysts Products Industry Segmentation

United States Biocatalysts Market Share

Transferase Enzymes are Leading the Biocatalysts Market Share Owing to Increased Adoption of Genetically Engineered Crops and Feed

As per the United States biocatalysts market analysis, transferase biocatalysts are widely used in the genetic engineering industry, particularly agricultural applications. They are essential in facilitating the insertion or modification of genes for the development of genetically modified organisms (GMO) including crops and feed. The country has been witnessing increased adoption of these products across the agricultural domain, propelling the demand for transferase biocatalysts. According to the US Department of Agriculture, the gene-edited herbicide-tolerant soybean reached its highest adoption at 96% of the total acreage in 2024. In the same year, the adoption of herbicide-tolerant cotton acreage stood at 93% in 2024 whereas that of herbicide-tolerant corn stood at 90%.

Moreover, the demand for hydrolase enzymes is expanding in the food and dairy sector due to new developments from key market players. They are not only being used to enhance the flavours and nutrient efficiency of food products but also are making food items suitable for the food consumption needs of the diverse population. For instance, Biocatalysts Ltd., a pioneer in the development of biocatalysts, announced the launch of its new Kosher and Halal-certified hydrolase enzyme Promod 517MDP, targeting the dairy protein market. It is a highly efficient exopeptidase that achieves more than 40 degrees of hydrolysis in casein protein, breaking it down into its smaller parts, peptides and amino acids which increases the solubility and improves the digestibility of food products.

Microorganisms-Based Biocatalysts Account for the Highest Biocatalysts Market Share in United States

Microorganisms-based biocatalysts account for the highest share in the industry owing to their applicability in a wide range of industrial processes such as biofuel production, food processing, and the synthesis of pharmaceutical products. Moreover, they are immensely sustainable as their biocatalytic processes produce minimal by-products and can be completed under mild conditions. Realising their growing popularity, several major industry leaders have enhanced the use of microbes in their biocatalyst production processes. For instance, Biocatalysts Ltd, a brainchild of the biotech giant, BRAIN Biotech AG, developed a platform “Plug & Produce” in August 2024 to scale up the manufacturing of bioenzymes with microbes such as yeast, bacteria, and fungi as hosts.

Besides, plant-based biocatalysts are also growing in popularity due to the changing food consumption patterns of the US population. Industry reports suggest that the country had a 1.5% vegan whereas 4.2% vegetarian population in 2024. Increasing globalisation and health concerns are causing a further rise in this share, propelling the demand for plant-based biocatalysts to enhance the flavour profile, texture, and shelf-life of vegetarian and vegan packaged food items and beverages.

Increased Use of Biocatalysts in the Food and Beverages Sector Propelling the Growth of Biocatalysts Industry in United States

Biocatalysts are widely used in the food and beverage industry to enhance the flavour, nutrients, and shelf-life of products, improving their overall quality for human consumption. They are particularly used to break down starches into sugar to produce sweeteners and ferment brewing as well as dairy beverages in the food processing industry. Their growing demand has encouraged major biocatalyst companies to increase their footprint in the food and beverages industry of the United States. In a similar effort, Biocatalysts Ltd., a major supplier of biocatalysts in the US launched Lipomod 4MDP in July 2021, a unique enzyme to flavour and increase the shelf-life of dairy products. This enzyme was Kosher and Halal certified, ensuring inclusivity of its use across all US regions.

Biofuel production, especially bioethanol and biodiesel, is also driving the United States biocatalysts market expansion. In this regard, enzymes such as cellulases and lipases are found to be frequently and most used. They facilitate easy conversion of biomass into biofuels, making the production process extremely efficient and eco-friendly. The US Department of Agriculture estimated the total bioethanol production at 15.4 billion gallons and the combined biodiesel and renewable diesel production at 3.1 billion gallons in 2022. With growing demand in the energy and transport sector, a further increase in biofuel production will create new opportunities for the market.

United States Biocatalysts Market Regional Analysis

The Great Lakes Region is Leading the United States Biocatalysts Market Owing to the Presence of Several Research and Innovation Centres

The Great Lakes region is leading the market due to the presence of several research and innovation centres such as the Northwestern University in Illinois, one of the most developed biotech research institutions in the region. These institutes, supported by public-private partnerships and research grants from the government are creating new United States biocatalysts market opportunities for regional as well as national players.

Similarly, the Far West region is the epicentre of the pharmaceutical industry in the US and its largest pharmaceutical market, California, was among the top six US states for pharmaceutical and medicine exports in 2023, generating a total export turnover of USD 9.3 billion. This indicates a high demand for biocatalysts in the region’s pharmaceutical manufacturing sector, as they are essential in enabling efficient, sustainable, and precise chemical reactions during drug synthesis.

Competitive Landscape

Other key players considered in the United States biocatalysts market report are BASF SE, Sterling Pharma Solutions Limited, AB Enzymes GmbH, Almac Group Limited, and Amano Enzyme Inc. among others.